Stantec affirms FY26 adj EPS guidance of $4.37-$4.49
Stantec reaffirms its FY26 financial outlook, maintaining adjusted EPS guidance of $4.37-$4.49 and sales guidance of $5.054B-$5.194B. These figures align closely with analyst estimates of $4.43 for EPS and $5.120B for sales, reflecting a stable consensus on the company's fiscal performance.

*this image is generated using AI for illustrative purposes only.
Stantec (NYSE: STN) has reaffirmed its financial guidance for fiscal year 2026, maintaining its previous outlook for both adjusted earnings per share (EPS) and total sales. The infrastructure consulting firm’s projections remain aligned with current analyst expectations, signaling stability in its near-term operational forecast.
The company continues to project adjusted EPS within the range of $4.37 to $4.49. This midpoint of approximately $4.43 matches the prevailing analyst estimate of $4.43, indicating that market participants’ expectations are in line with management’s internal forecasts.
On the topline, Stantec affirmed its sales guidance of $5.054 billion to $5.194 billion. This range brackets the analyst consensus estimate of $5.120 billion, suggesting that the company anticipates delivering revenue performance consistent with street expectations.
Guidance Metrics
| Metric: | Guidance Range: | Analyst Estimate: |
|---|---|---|
| Adjusted EPS: | $4.37 – $4.49 | $4.43 |
| Sales: | $5.054B – $5.194B | $5.120B |
What the Numbers Show
The alignment between Stantec’s guided ranges and analyst estimates suggests a high degree of consensus on the company’s FY26 trajectory. With the midpoint of the EPS guidance matching the estimate exactly and the sales consensus falling comfortably within the guided band, there is minimal dispersion between management’s outlook and market pricing. This tight correlation typically indicates low uncertainty regarding near-term execution risks or macroeconomic headwinds affecting the firm’s core engineering and environmental services business.
How might Stantec's reaffirmed guidance influence its valuation multiples relative to peers in the infrastructure consulting sector?
What specific macroeconomic risks or regulatory changes could threaten Stantec's ability to hit the midpoint of its EPS guidance in FY26?
Is Stantec planning to adjust its capital allocation strategy, such as share buybacks or dividend increases, given the stability of its near-term outlook?






























